Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

Fig. 11.

Fig. 12.

Fig. 13.

Fig. 14.

Fig. 15.

Fig. 16.

Fig. 17.

Fig. 18.

Fig. 19.

Fig. 20.

Features which favor malignancy in soft tissue tumors
| 1. | Progressive growth of tumor clinically (particularly if growth is rapid and patient has or had known primary tumor) |
| 2. | Middle-aged or elderly patient |
| 3. | Medium to large-sized tumor (>2 cm if superficial), (>3 cm if deep) |
| 4. | Moderate to severe tumor hyperemia (if superficial) Mild to moderate tumor hyperemia (if deep) |
| 5. | More rounded, rather than elongated, tumor shape |
| 6. | Chaotic, rather than organized, tumoral vascular pattern |
| 7. | Lack of similarity with the known US appearances of particular benign soft tissue masses |
Based on data compiled from the references Hung et al_4 and Griffith et al_5 The studies employed identical methodology to investigate the accuracy of US when experienced examiners were confident about the US diagnosis of (both neoplastic and non-neoplastic) superficial and deep soft tissue masses_ Masses without histology were followed up clinically_ Of 1,402 soft tissue masses studied, the examiner was confident about the type of mass in 71–75% of cases_ Compared to histology, this confident diagnosis was correct in 95-96% of cases_ Of the nine incorrect diagnoses, eight were benign tumors found to be another type of benign tumor_ The ninth case was considered to be a benign tumor (calcified granuloma) on US, though it was found to be malignant histologically (calcified metastasis)_ Therefore, for patients with a confident US diagnosis, malignancy was overlooked in only <0_1% of soft tissue masses overall and in <0_3% in those with histology
| Superficial masses | Deep masses | |
|---|---|---|
| Number of masses studied (n = 1402) | 823 | 579 |
| ‘Confident diagnosis’ regarding nature of mass | 585 (71%) | 436 (75%) |
| Number of masses with subsequent histology | 219/823 (27%) | 134/579 (34%) |
| ‘Confident diagnosis’ regarding nature of mass in masses with histology | 132/219 (60%) | 67/134 (57%) |
| Correct ‘confident diagnosis’ compared to histology | 126/132 (95%) | 64/67 (96%) |
Incorrect confident diagnosis for superficial masses (n = 6):
| ||
Incorrect confident diagnosis for deep masses (n = 3):
| ||
Suggested further work-up of soft tissue tumors following US assessment in situations where (a) one is confident regarding ultrasound diagnosis, or when the ultrasound diagnosis is not certain, though there is (b) no evidence of malignancy or (c) possibility of malignancy
| Confident regarding diagnosis | Indeterminate mass with no evidence of malignancy | Indeterminate mass with possibility of malignancys |
|---|---|---|
Provide definitive diagnosis. If benign, no need for additional investigation in most instances. If considered malignant, proceed to: percutaneous biopsy ± MRI. | List three most likely diagnoses ± comment that tumor is much more likely to be benign rather than malignant. Proceed to either:
| Proceed to:
|
Some soft tissue masses (both neoplastic and non-neoplastic) which tend to have a more distinctive US appearance_ The perceived frequency with which each of these specific tumors can be characterized based on US assessment alone is also provided_
| Superficial | Deep | ||
|---|---|---|---|
| Neoplastic | Non-neoplastic | Neoplastic | Non-neoplastic |
| Lipoma and variantsA | Epidermoid cystB | Lipoma and variantsA | Elastofibroma dorsiA |
| Vascular anatomyB | Inflammatory massA | GCTTSB | GanglionA |
| Nerve sheath tumorsC | Foreign body granulomaB | Plantar or palmar fibromaA | Bakers’ cystA |
| PilomatrixomaC | Calcified or injection granulomaA | Fibromatosis (desmoid tumor)B | HerniaA |
| Lymph nodeA | Fat necrosisB | MyxomaC | Gouty tophusB |
| LeiomyomaC | Rheumatoid noduleB | SarcomaB | HematomaB |
| Subcutaneous lymphomaC | Panniculitis-like massC | Subcutaneous lymphomaC | Varix, pseudoaneurysm, aneurysmA |
| LymphoceleB | |||
| Lipohypertrophy/lipomatosisA | Myositis ossificansB | ||
| Encysted fluid spermatic cord/canal of NuckB | Muscle hypertrophyA | ||
| Abscess or collectionA | |||
| Intravascular papillary epithelial | Morton’s neuromaB | ||
| hypertrophyC | BursitisA | ||
| Organizing hematomaB | EndometriosisC | ||
| Tumoral calcinosisB | XanthomaC | ||
| Accessory breast issueA | |||
Potential advantages of MRI over US in the assessment of soft tissue masses
|